BACKGROUND: Little is known about the prevalence of attention-deficit hyperactivity disorder (ADHD) among older adults. AIMS: To estimate the prevalence of the syndromatic and symptomatic DSM-IV ADHD diagnosis in older adults in The Netherlands. METHOD: Data were used from the Longitudinal Aging Study Amsterdam (LASA). At baseline, 1494 participants were screened with an ADHD questionnaire and in 231 respondents a structured diagnostic interview was administered. The weighted prevalence of ADHD was calculated. RESULTS: The estimated prevalence rate of syndromatic ADHD in older adults was 2.8%; for symptomatic ADHD the rate was 4.2%. Younger elderly adults (60-70 years) reported significantly more ADHD symptoms than older elderly adults (71-94 years). CONCLUSIONS: This is the first epidemiological study on ADHD in older persons. With a prevalence of 2.8% the study demonstrates that ADHD does not fade or disappear in adulthood and that it is a topic very much worthy of further study.
BACKGROUND: Little is known about the prevalence of attention-deficit hyperactivity disorder (ADHD) among older adults. AIMS: To estimate the prevalence of the syndromatic and symptomatic DSM-IV ADHD diagnosis in older adults in The Netherlands. METHOD: Data were used from the Longitudinal Aging Study Amsterdam (LASA). At baseline, 1494 participants were screened with an ADHD questionnaire and in 231 respondents a structured diagnostic interview was administered. The weighted prevalence of ADHD was calculated. RESULTS: The estimated prevalence rate of syndromatic ADHD in older adults was 2.8%; for symptomatic ADHD the rate was 4.2%. Younger elderly adults (60-70 years) reported significantly more ADHD symptoms than older elderly adults (71-94 years). CONCLUSIONS: This is the first epidemiological study on ADHD in older persons. With a prevalence of 2.8% the study demonstrates that ADHD does not fade or disappear in adulthood and that it is a topic very much worthy of further study.
Authors: Susan Young; Jack Hollingdale; Michael Absoud; Patrick Bolton; Polly Branney; William Colley; Emily Craze; Mayuri Dave; Quinton Deeley; Emad Farrag; Gisli Gudjonsson; Peter Hill; Ho-Lan Liang; Clodagh Murphy; Peri Mackintosh; Marianna Murin; Fintan O'Regan; Dennis Ougrin; Patricia Rios; Nancy Stover; Eric Taylor; Emma Woodhouse Journal: BMC Med Date: 2020-05-25 Impact factor: 8.775
Authors: Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-05-28 Impact factor: 4.328
Authors: Annemarie van der Kolk; Clazien Am Bouwmans; Saskia J Schawo; Jan K Buitelaar; Michel van Agthoven; Leona Hakkaart-van Roijen Journal: Springerplus Date: 2015-05-15
Authors: Julia Huemer; Anita Riegler; Sabine Völkl-Kernstock; Alexander Wascher; Otto M Lesch; Henriette Walter; Katrin Skala Journal: Neuropsychiatr Date: 2016-10-06
Authors: Emiel O Hoogendijk; Dorly J H Deeg; Jan Poppelaars; Marleen van der Horst; Marjolein I Broese van Groenou; Hannie C Comijs; H Roeline W Pasman; Natasja M van Schoor; Bianca Suanet; Fleur Thomése; Theo G van Tilburg; Marjolein Visser; Martijn Huisman Journal: Eur J Epidemiol Date: 2016-08-20 Impact factor: 8.082